Do CHA2DS2VASc and HAS‐BLED scores influence ‘real‐world’ anticoagulation management in atrial fibrillation? 1556 patient registry from the reference cardiology centre
ConclusionsAntithrombotic management in AF is well implemented in Polish conditions, but we show the lack of pattern concerning who is being treated with OAC and ASA when it comes to the risk of stroke and bleeding. Copyright © 2015 John Wiley & Sons, Ltd.
Source: Pharmacoepidemiology and Drug Safety - Category: Drugs & Pharmacology Authors: Paulina Lopatowska, Anna Tomaszuk‐Kazberuk, Elzbieta Mlodawska, Hanna Bachorzewska‐Gajewska, Jolanta Malyszko, Slawomir Dobrzycki, Wlodzimierz J. Musial Tags: Original Report Source Type: research
More News: Anemia | Atrial Fibrillation | Bleeding | Cardiology | Drugs & Pharmacology | Heart | Heart Attack | Heart Disease | Heart Failure | Ischemic Stroke | Stroke | Study | Vitamins